Analystreport

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is now covered by analysts at SVB Leerink LLC. They set a "buy" rating and a $178.00 price target on the stock.

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations